Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01811472

Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients

Non-alcoholic Fatty Liver Disease (NAFLD) Clinical Trial

Official title:
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group, 24-week Pilot Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in Patients With Non-alcoholic Fatty Liver Disease

Clinical Trial Summary

The purpose of this study was to determine whether LCQ908 effectively lowers liver fat, as assessed by MRI and to assess its safety and tolerability profile in subjects with non-alcoholic fatty liver disease (NAFLD).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01811472
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 2
Start date June 2013
Completion date September 2014
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04099147 - Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
Completed NCT04019561 - A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. Phase 2
Withdrawn NCT00375349 - Non Alcoholic Fatty Liver Disease Influence of Statin Therapy N/A
Active, not recruiting NCT04682600 - The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF N/A
Terminated NCT02605616 - Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) Phase 2
Completed NCT04165343 - Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER
Recruiting NCT03151473 - Longitudinal Observational Study Of Chinese With NAFLD/NASH
Recruiting NCT04820036 - A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) N/A
Active, not recruiting NCT02037321 - Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk N/A
Completed NCT01997424 - Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus N/A
Completed NCT01110577 - Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171) N/A
Completed NCT00771108 - Exercise Dose and Nonalcoholic Fatty Liver Disease N/A
Recruiting NCT04639414 - Combined Active Treatment in Type 2 Diabetes With NASH Phase 4
Completed NCT04450875 - Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD N/A
Recruiting NCT02654665 - Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults Phase 3
Recruiting NCT05699018 - Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients N/A
Withdrawn NCT02457286 - Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study Phase 1
Withdrawn NCT02194894 - The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients N/A
Completed NCT00968747 - Regulation of FGF21 by Nutritional Challenges N/A
Recruiting NCT04330326 - Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease Phase 2